SNN
Smith+Nephew plc (NYSE: SNN) announced expanded enterprise ASC Solutions strategy for ambulatory surgery...
Article Summary
BUY- Smith+Nephew plc (NYSE: SNN) announced expanded enterprise ASC Solutions strategy for ambulatory surgery centers, with ASC Solutions taking customer-centric approach to helping ASC customers realise key objectives of cost optimization, quality, and outcome performance.
- ASC Solutions helps customers source best-in-class expertise, differentiated procedural technologies and advanced data and analytics to help ASCs accelerate growth, improve operational performance, and drive patient outcomes within increasingly complex and value-based care environment.
- The global medical technology company is expanding ASC ONE delivery model into integrated platform designed to simplify ASC development, accelerate facility readiness, and support long-term operational success, bringing together network partners to support development planning, facility design and construction, operating company formation, financing, sterile processing, information technology infrastructure, and clinical enablement within coordinated framework.
- Unlike traditional approaches that require customers to manage multiple vendors and disconnected workstreams, ASC ONE provides streamlined experience through single point of coordination within strategic network helping reduce complexity, improve execution, and accelerate timelines.
Free users see 3 BUY signals per day. Premium unlocks all of them, plus instant email alerts.
See Plans
Growth Stock Scoring Breakdown
| METRIC | VALUE | WEIGHT | ANALYSIS |
|---|---|---|---|
| Sales Growth TTM ? | 6.3% | 25% | 35.0 ptsBelow Screener (6.3%) - Weak growth |
| EPS Growth Next 5Y ? | 10.4% | 25% | 35.0 ptsBelow Screener (10.4%) - Modest outlook |
| Target Price Upside ? | 18.2% | 20% | 60.0 ptsModerate Upside (18.2%) - Target: $35.68 vs Current: $30.18 |
| Gross Margin % ? | 68.0% | 15% | 80.0 ptsVery Healthy (68.0%) - High-quality margins |
| Drawdown from 52-Wk High ? | -22.2% | 15% | 40.0 ptsMild Pullback (-22.2%) - Light entry opportunity |
Disclaimer: This rating is for informational purposes only and is not financial advice.
All data sourced from Finviz.
Always conduct your own research and consult with a financial advisor before making investment decisions.
Past performance does not guarantee future results.
About SNN
- Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally.
- The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.
- It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
- The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints.
- In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions.
- Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems.
- It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.